SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-24-014146
Filing Date
2024-02-14
Accepted
2024-02-14 17:04:25
Documents
20
Period of Report
2024-02-14

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea192898-pre14a_onconetix.htm PRE 14A 3570850
2 GRAPHIC annexc_001.jpg GRAPHIC 10276
3 GRAPHIC image_001.jpg GRAPHIC 137264
4 GRAPHIC image_002.jpg GRAPHIC 53880
5 GRAPHIC image_003.jpg GRAPHIC 53606
6 GRAPHIC image_004.jpg GRAPHIC 13899
7 GRAPHIC image_005.jpg GRAPHIC 22171
8 GRAPHIC image_008.jpg GRAPHIC 30079
9 GRAPHIC image_009.jpg GRAPHIC 12160
10 GRAPHIC image_010.jpg GRAPHIC 10937
11 GRAPHIC image_011.jpg GRAPHIC 35154
12 GRAPHIC image_012.jpg GRAPHIC 39967
13 GRAPHIC image_013.jpg GRAPHIC 39944
14 GRAPHIC image_014.jpg GRAPHIC 49353
15 GRAPHIC image_015.jpg GRAPHIC 84074
16 GRAPHIC image_016.jpg GRAPHIC 10318
17 GRAPHIC image_017.jpg GRAPHIC 11050
18 GRAPHIC image_018.jpg GRAPHIC 40158
19 GRAPHIC image_019.jpg GRAPHIC 34783
20 GRAPHIC image_020.jpg GRAPHIC 44984
  Complete submission text file 0001213900-24-014146.txt   4585585
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-41294 | Film No.: 24640243
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)